1. Home
  2. BNL vs VCYT Comparison

BNL vs VCYT Comparison

Compare BNL & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNL
  • VCYT
  • Stock Information
  • Founded
  • BNL 2007
  • VCYT 2006
  • Country
  • BNL United States
  • VCYT United States
  • Employees
  • BNL N/A
  • VCYT 824
  • Industry
  • BNL Real Estate Investment Trusts
  • VCYT Medical Specialities
  • Sector
  • BNL Real Estate
  • VCYT Health Care
  • Exchange
  • BNL Nasdaq
  • VCYT Nasdaq
  • Market Cap
  • BNL 3.5B
  • VCYT 2.8B
  • IPO Year
  • BNL 2020
  • VCYT 2013
  • Fundamental
  • Price
  • BNL $18.61
  • VCYT $35.81
  • Analyst Decision
  • BNL Buy
  • VCYT Strong Buy
  • Analyst Count
  • BNL 7
  • VCYT 9
  • Target Price
  • BNL $19.71
  • VCYT $40.44
  • AVG Volume (30 Days)
  • BNL 1.8M
  • VCYT 812.6K
  • Earning Date
  • BNL 10-29-2025
  • VCYT 11-04-2025
  • Dividend Yield
  • BNL 6.19%
  • VCYT N/A
  • EPS Growth
  • BNL N/A
  • VCYT N/A
  • EPS
  • BNL 0.52
  • VCYT 0.34
  • Revenue
  • BNL $442,203,000.00
  • VCYT $479,129,000.00
  • Revenue This Year
  • BNL $5.28
  • VCYT $14.48
  • Revenue Next Year
  • BNL $6.26
  • VCYT $9.79
  • P/E Ratio
  • BNL $36.12
  • VCYT $106.72
  • Revenue Growth
  • BNL 3.85
  • VCYT 19.91
  • 52 Week Low
  • BNL $13.96
  • VCYT $22.61
  • 52 Week High
  • BNL $18.86
  • VCYT $47.32
  • Technical
  • Relative Strength Index (RSI)
  • BNL 58.89
  • VCYT 62.31
  • Support Level
  • BNL $17.97
  • VCYT $33.20
  • Resistance Level
  • BNL $18.75
  • VCYT $35.33
  • Average True Range (ATR)
  • BNL 0.32
  • VCYT 1.35
  • MACD
  • BNL 0.00
  • VCYT -0.13
  • Stochastic Oscillator
  • BNL 85.66
  • VCYT 71.10

About BNL Broadstone Net Lease Inc.

Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

Share on Social Networks: